Clinical Updates & Insights

Share
Print

Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers.

197 Clinical Updates found

Clinical Update

Best Practices for Managing Cancer Surgery during the COVID-19 Pandemic

Memorial Sloan Kettering has convened a COVID-19 Operating Room Executive Committee to scrutinize all surgical cases and determine whether they were truly essential and to review needs, resources, and ICU availability.

  • Monday, May 11, 2020

Clinical Update

CAR T Cell Therapy Should Proceed During the COVID-19 Pandemic

Treatment with chimeric antigen receptor T cell therapy should proceed in patients with B cell non-Hodgkin lymphomas and B cell acute lymphocytic leukemia, despite Covid-19 according to the CAR T Cell Consortium, a collaboration of investigators from eight U.S. academic institutions.

  • Monday, May 11, 2020

Clinical Update

Evidence-Based Approaches to Defer or Shorten Breast Radiotherapy during the COVID-19 Pandemic

During the early days of the COVID-19 outbreak, a team of radiation oncologists specializing in breast cancer management at Memorial Sloan Kettering Cancer Center reviewed the literature and established recommendations for the safe use of hypofractionated and abbreviated radiation regimens for our patients with breast cancer.

  • Monday, May 11, 2020

Clinical Update

Managing Locally Advanced Rectal Cancer with Short-Course Radiation Therapy During the COVID-19 Pandemic

The pandemic has raised important issues for clinicians, and, after weighing the risks and benefits, the Colorectal Disease Management Team at MSK decided that all patients with locally advanced colorectal cancer will be treated with short-course radiation therapy rather than standard long-course chemoradiation therapy.

  • Monday, May 11, 2020

Clinical Update

The Best Preoperative Assessment Tools for Patients Undergoing Surgery for Secondary Upper Extremity Lymphedema

For the past five years, we have prospectively evaluated patients with secondary lymphedema of the upper extremity who presented for surgical consultation at Memorial Sloan Kettering Cancer Center (MSK).

  • Wednesday, April 8, 2020

Clinical Update

CAR T May Be Beneficial and Safe in Older Patients with Relapsed/Refractory LBCL and Geriatric Vulnerabilities

Older, vulnerable patients with relapsed/refractory large B cell lymphoma should receive the same consideration for CAR T cell therapy as younger patients.

  • Friday, April 3, 2020

Clinical Update

PROs Crucial in Cost Analyses of Reconstruction Options Straight After Mastectomy

When comparing options for immediate breast reconstruction after mastectomy, cost analyses should include patient-reported outcome (PRO) measures, such as BREAST-Q scales and complication rates.

  • Friday, March 6, 2020

Clinical Update

Very Low-Dose Radiotherapy Effective for Grade 3A Follicular Lymphoma

Very low-dose radiotherapy (VLDRT) is effective for treating grade 3A follicular lymphoma and provides patients with a shorter treatment course and fewer side effects.

  • Friday, March 6, 2020

Clinical Update

Breast Density, Not BMI, Linked to Higher Cancer Risk in Lobular Carcinoma in Situ

Increased breast density, but not BMI, is an additional risk factor for breast cancer in women with lobular carcinoma in situ (LCIS).

  • Thursday, January 30, 2020

Clinical Update

Less Lymphedema with SLN Mapping vs Lymphadenectomy Post Hysterectomy for Endometrial Cancer

Sentinel lymph node (SLN) mapping leads to significantly less lower-extremity lymphedema compared to comprehensive lymphadenectomy (LND) after hysterectomy in patients with endometrial cancer.

  • Thursday, January 30, 2020